DOCSLIB.ORG

669 L.S. Medina Et Al. (Eds.), Evidence-Based Imaging: Improving The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
669 L.S. Medina Et Al. (Eds.), Evidence-Based Imaging: Improving The Index A small bowel obstruction, Acute hematogenous Abdomen, blunt trauma 469–471, 474 osteomyelitis imaging bowel/mesentery imaging, See also specific disorders case studies (images), 303– 306 445–446 Acute abdomen. See Abdominal and diabetic foot, 302 case studies (images), 159, pain, acute diagnostic accuracy, 300–301 448–449 Acute afebrile symptomatic future directions, 306 costs, 442–443 seizures goals of, 299 CT, 448–450, 463 incidence, 247 imaging protocols, 303 Doppler ultrasound, 446 See also Seizures neuroimaging literature search, 299 epidemiology, 442 Acute aortic dissection MRI, 300 future directions, 450 CT angiography, 420 radionuclide bone imaging protocol, 367 imaging cost-effectiveness, 417 scintigraphy, 300 literature search, 443 imaging goals, 416–417 repeat imaging, 301–302 pathophysiology, 442 pathophysiology, 416 ultrasound, 301 retroperitonal injuries Acute appendicitis. See Acute limb ischemia, 416 imaging, 446–448 Appendicitis, acute Adolescent idiopathic scoliosis, spleen/liver imaging, 445 Acute calculous cholecystitis 371–372, 374–376 types of injuries, 441–450 case studies (images), 564–565 Adrenal gland ultrasound, 450 cholescintigraphy, 506–507 blunt trauma, imaging, Abdominal aortic aneurysms costs, 505 363–364 (AAA) CT, 507 metastasis, and lung cancer, endovascular vs. surgical, epidemiology, 505 95, 96 418–419 imaging goals, 505 Alzheimer’s disease treatment, 418–419 imaging strategy, 506–507 clinical criteria, accuracy of, imaging cost-effectiveness, 417 MR 169–170 mortality and screening, cholangiopancreatography, costs, 168 417–418 507 epidemiology, 168 pathophysiology, 416 MRI, 507 genetic susceptibility, 172 stent-graft endoleaks, pathophysiology, 504–505 Alzheimer’s disease 420–421 ultrasound, 506 neuroimaging Abdominal pain, acute Acute hematogenous at-risk persons, identifying, 168 appendicitis, 468 osteomyelitis cost effectiveness, 173–174 colonic diverticulitis, 471–473 clinical signs, 301 CT, 190–191 common causes, 468 costs, 299 for disease progression, 170 costs, 469 epidemiology, 298–299 functional imaging, 171 epidemiology, 468–469 long-term effects, 298, 299, 301 goals of, 168 imaging goals, 469 medical therapy versus literature search, 169 literature search, 469 surgery, 301 MRI, 171–172 small bowel ischemia, pathogens, 300 PET, 171, 175–176 470–471, 474 pathophysiology, 298 PET FDG, 175 L.S. Medina et al. (eds.), Evidence-Based Imaging: Improving the Quality of Imaging in Patient Care, Revised Edition, 669 DOI 10.1007/978-1-4419-7777-9, © Springer Science+Business Media, LLC 2011 670 Index Alzheimer’s disease Bayes’ theorem, 12, 13, 15–16 costs, 505, 515 neuroimaging (cont.) Bias, 7, 11, 19–26, 66, 68, 92, 98, epidemiology, 505 proton MR spectroscopy 119, 219, 264, 313, 314, future directions, 524 (1HMRS), 190 338–340, 342–344, 364, 374, imaging goals, 505 SPECT, 171 405, 419, 422, 431, 432, 459, literature search, 507, 512 structural neuroimaging, 460, 470–472, 618 pathophysiology, 504–505 170–172 lead-time, 23 See also specific disorders for therapeutic efficacy, length-time, 23 Bladder 174–175 observer, 7, 22, 24 blunt trauma, imaging, 445 Analytical studies, 6 reference standard, 22, 24, disorders. See Urinary tract Aneurysms. See Abdominal aortic 340, 459 disorders aneurysms; Intercranial screening selection, 23 Blinding aneurysms selection, 11, 22–25, 66, 219, clinical studies, 6–7 Angiography 264, 342, 405, 419, 460 vs. not blinding, 22 pulmonary, 403 slippery linkage, 23 Blunt trauma See also Computed sticky diagnosis, 23 aortic rupture, 416 tomography angiography Bile duct obstruction, 503–524 thoracolumbar spine imaging, (CTA); Coronary computed tomography (CT), 363–367 angiography; Magnetic 507–517, 520, 523 See also Abdomen, blunt resonance angiography endoscopic ultrasonography, trauma; Chest, blunt (MRA) 511, 512, 514–515, 517 trauma Angioplasty and stenting, carotid epidemiology, 505 Bone metastasis stenosis, 430, 433–434 magnetic resonance from lung cancer, 95–97 Ankylosing spondylitis, cholangiopancreatography from prostate cancer, 156–159 MRI, 344 (MRCP), 507, 509–516, Bone scan. See Radionuclide bone radionuclide bone 521–524 scintigraphy scintigraphy, 303 magnetic resonance imaging Bowel SPECT, 344 (MRI), 507, 513–515, 523 blunt trauma, imaging, X-rays, 347 pathophysiology, 504–505 445–446 Anterior spinal meningocele, 370 ultrasound, 506 invagination. See Aorta Bile duct stricture, 503–524 Intussusception abdominal aortic aneurysms computed tomography (CT), ischemia. See Small bowel (AAA), 417–418 507–517, 520, 523 ischemia acute aortic dissection, 417 endoscopic retrograde obstruction. See Small bowel aortic rupture, 416 cholangiopancreatography obstruction See also specific disorders (ERCP), 509–515, 521, 523 Brain Aortic dissection. See Acute aortic endoscopic ultrasonography, atropy, 170, 172–174, 178, 201, dissection 511, 512, 514–515, 517 225, 234, 249, 251, 256 Appendicitis, acute, imaging strategy, 506–523 imaging. See Neuroimaging case studies (images), 462–464 Klatskin tumor, 515–516, 522 Brain cancer costs, 458 magnetic resonance clinical signs, 128, 130–133, CT, 458–459 cholangiopancreatography 135–138, 140, 141, 145 defined, 458 (MRCP), 507, 509–516, costs, 130, 137, 145 diagnostic accuracy, 459 521–524 epidemiology, 128–130, 132 future directions, 465 percutaneous transhepatic forms of, 128 graded compression cholangiography (PTC), pediatric cases, 129–130, 132, ultrasound, 458–460 514, 522 133, 136, 145 imaging protocol, 460 ultrasonography, 506–517, unique nature of, 128 literature search, 460 519–521, 523 Brain cancer neuroimaging pathophysiology, 458 Biliary disorders case studies (images), 129, 131, pediatric cases, 458 acute calculous cholecystitis 134–135 ultrasound, 458–460 (ACC), 505–508, 517, 519 cost effectiveness, 130, 132, Arthritis, septic. See Septic bile duct obstruction, 505, 506, 133, 136–138, 145 arthritis 508, 510–511, 515, 516, 523 CT, 130, 132–134, 137–142 bile duct stricture, 505, decision-making flowchart, 513–524 140 B choledocholithiasis, 505, diffusion-weighted imaging Back pain. See Low back pain 511–513, 517, 521, 523 (DWI), 135, 139, 142, 145 Barium, negative aspects of use, chronic calculous cholecystitis, goals of, 130 482, 485 508–509, 521 indications for, 136 Index 671 literature review, 131, 135 CT calcium scoring, 389 in high-risk patients, 360–362 MRI, 130, 132–139, 144, 145 future directions, 399 indications for, 367 PET FDG, 133, 134, 136–138 goals of, 388–389 literature search, 359 proton MR spectroscopy, literature search, 388 NEXUS prediction rule, 359 134–136, 139 MRI, 394 and unconscious patient, 365 SPECT, 133, 134, 136–138, 145 PET, 391 Cervical spine injury symptomatology criteria, 131 SPECT, 393, 394 costs, 358 tumors vs. tumor-mimicking stress echocardiography, 388 epidemiology, 358 lesions, 135 stress electrocardiography, 392 Chest, blunt trauma Brain ischemia, imaging methods, Carotid imaging chest wall imaging, 102 187–189 of asymptomatic patients, costs, 442–443 Brain metastasis 432–433 CT, 443 and headache, 265 catheter angiography (CA), CT angiography, 443 from lung cancer, 129, 137 432 definition, 442 Brain swelling, traumatic brain cost-effectiveness, 433, 436 diaphragm imaging, 444 injury imaging, 223 CT angiography, 428, 437 epidemiology, 442 Breast cancer Doppler ultrasound (DUS), goals, 443 at-risk persons, 32, 37, 63, 65, 432, 438 literature search, 443 67–69, 85, 375 goals of, 429 MRI, 444 costs, 64, 68 literature review, 431 pathophysiology, 442 epidemiology, 63 MR angiography, 431 pleura/lung imaging, 443–444 grades, 63, 69 multiple overlapping thinslab X-rays, 443 scoliosis imaging as cause, acquisition (MOTSA), 431 Children 32, 375 transcranial Doppler appendicitis, acute, 459–461 Breast cancer imaging (TCD), 434 brain cancer, 131–132 and BIRADS category 3 Carotid stenosis cervical spine imaging, 360 lesions, 71 and stroke risk, 435–436 gastrointestinal tract case studies (images), 63, 64, angioplasty and stenting, obstruction. See 66–68, 71–73 433–434 Intussusception future directions, 85 carotid endarterectomy, headache/headache goals of, 64 effectiveness, 433 neuroimaging, 268 image-guided percutaneous cerebral blood flow Ottawa knee rule, 328, 332 biopsy, 64, 71, 80 assessment, 435 seizures/seizures literature review, 64 cerebral blood volume neuroimaging, 248–250 literature search, 64 assessment, 233 sinusitis imaging, 279–281 magnetic resonance imaging complete occlusion, 431 spinal disorders. See Occult (MRI), 69, 70, 73 costs, 433, 436 spinal dysraphism; mammographic screening, 47, epidemiology, 429 Scoliosis 63–66, 68, 85 pathophysiology, 428 and stroke, 206–207 and nipple discharge, 70 Case-control studies, 111 thoracolumbar spine and radial scars, 71, 78, 80 Catheter angiography (CA), imaging, 363 ultrasound, 64, 68–69, 76 carotid imaging, 432 traumatic brain injury Cauda equina syndrome, 338 imaging, 225–229 Caudal regression syndrome, Cholecystitis. See Acute calculous C 370, 372 cholecystitis; Chronic Calcification scoring, coronary CBTRUS database, 131 calculous cholecystitis artery, 389–390 Cerebral blood flow assessment, Choledocholithiasis Calculous cholecystitis. See Acute carotid stenosis, 435 CT, 511–512 calculous cholecystitis; Cerebral blood volume endoscopic retrograde Chronic calculous assessment, carotid cholangiopancreatography cholecystitis stenosis, 233 (ERCP), 514 Canadian C-spine rule, 359, 360, Cervical spine imaging endoscopic ultrasonography, 364, 365 Canadian C-spine rule, 514–515 Cancer risk, scoliosis 359, 364 epidemiology, 495 imaging,
Load more

Recommended publications
  • ACR Appropriateness Criteria® Right Upper Quadrant Pain
    Revised 2018 American College of Radiology ACR Appropriateness Criteria® Right Upper Quadrant Pain Variant 1: Right upper quadrant pain. Suspected biliary disease. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US abdomen Usually Appropriate O CT abdomen with IV contrast May Be Appropriate ☢☢☢ MRI abdomen without and with IV May Be Appropriate contrast with MRCP O MRI abdomen without IV contrast with May Be Appropriate MRCP O Nuclear medicine scan gallbladder May Be Appropriate ☢☢ CT abdomen without IV contrast May Be Appropriate ☢☢☢ CT abdomen without and with IV Usually Not Appropriate contrast ☢☢☢☢ Variant 2: Right upper quadrant pain. No fever or high white blood cell (WBC) count. Suspected biliary disease. Negative or equivocal ultrasound. Procedure Appropriateness Category Relative Radiation Level MRI abdomen without and with IV Usually Appropriate contrast with MRCP O CT abdomen with IV contrast Usually Appropriate ☢☢☢ MRI abdomen without IV contrast with Usually Appropriate MRCP O Nuclear medicine scan gallbladder May Be Appropriate ☢☢ CT abdomen without IV contrast May Be Appropriate ☢☢☢ CT abdomen without and with IV Usually Not Appropriate contrast ☢☢☢☢ Variant 3: Right upper quadrant pain. Fever, elevated WBC count. Suspected biliary disease. Negative or equivocal ultrasound. Procedure Appropriateness Category Relative Radiation Level MRI abdomen without and with IV Usually Appropriate contrast with MRCP O CT abdomen with IV contrast Usually Appropriate ☢☢☢ Nuclear medicine scan gallbladder Usually Appropriate ☢☢ MRI abdomen without IV contrast with May Be Appropriate MRCP O CT abdomen without IV contrast May Be Appropriate ☢☢☢ CT abdomen without and with IV Usually Not Appropriate contrast ☢☢☢☢ ACR Appropriateness Criteria® 1 Right Upper Quadrant Pain Variant 4: Right upper quadrant pain.
    [Show full text]
  • Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement
    Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement Harvey A. Ziessman, MD; Douglas A. Jones, MD; Larry R. Muenz, PhD; and Anup K. Agarval, MS Department of Radiology, Georgetown University Hospital, Washington, DC Fatty meals have been used by investigators and clini- The purpose of this investigation was to evaluate the use of a cians over the years to evaluate gallbladder contraction in commercially available lactose-free fatty-meal food supple- conjunction with oral cholecystography, ultrasonography, ment, as an alternative to sincalide cholescintigraphy, to de- and cholescintigraphy. Proponents assert that fatty meals velop a standard methodology, and to determine normal gall- are physiologic and low in cost. Numerous different fatty bladder ejection fractions (GBEFs) for this supplement. meals have been used. Many are institution specific. Meth- Methods: Twenty healthy volunteers all had negative medical histories for hepatobiliary and gallbladder disease, had no per- odologies have differed, and few investigations have stud- sonal or family history of hepatobiliary disease, and were not ied a sufficient number of subjects to establish valid normal taking any medication known to affect gallbladder emptying. All GBEFs for the specific meal. Whole milk and half-and-half were prescreened with a complete blood cell count, compre- have the advantage of being simple to prepare and admin- hensive metabolic profile, gallbladder and liver ultrasonography, ister (4–7). Milk has been particularly well investigated. and conventional cholescintigraphy. Three of the 20 subjects Large numbers of healthy subjects have been studied, a were eliminated from the final analysis because of an abnormal- clear methodology described, and normal values determined ity in one of the above studies.
    [Show full text]
  • The Diagnosis of Acute Cholecystitis: Sensitivity of Sonography
    The Diagnosis of Acute Cholecystitis: Sensitivity of Sonography, Cholescintigraphy and Computed Tomography Patthisak Changphaisarnkul MD*, Supakajee Saengruang-Orn PhD*, Trirat Boonya-Asadorn MD* * Division of Radiology, Phramonkutklao Hospital, Bangkok, Thailand Objective: To compare the sensitivity of sonographic, cholescintigraphic, and computed tomographic examination of acute cholecystitis to the pathology result, which is considered the Gold Standard. Material and Method: A retrospective analytic study was conducted among 412 patients, aged between 15 and 98 years, who underwent cholecystectomy surgeries, and whose pathology results indicated acute cholecystitis between July 2004 and May 2013. The sensitivity and the differences between sensitivity of the three methods were calculated in all patients. Complicated acute cholecystitis cases were analyzed separately. Results: The three methods demonstrated statistically significant differences in sensitivity (p-value = 0.017), with the cholescintigraphy as the most sensitive method (84.2%), followed by computed tomography (67.3%), and sonography (59.8%). Concerning the samples with the pathology result indicating complicated acute cholecystitis, computed tomography was statistically significantly more sensitive than sonography in detecting acute cholecystitis, whether or not the complications were identified (100% and 63.6%, respectively, with p-value = 0.0055). None of the patients with the pathology result of complicated acute cholecystitis case was examined by cholescintigraphy, thus, no calculation was possible. Regarding the ability to detect the complications of acute cholecystitis, computed tomography had a sensitivity of 35.71% (5 in 14 patients), while sonographic examinations could not detect any of the complications. Conclusion: Cholescintigraphy is a more sensitive method than computed tomography and sonography, but the three methods have its own advantages, disadvantages, and limitations, which must be considered for each individual patient.
    [Show full text]
  • Imaging Indication Guidelines
    IMAGING INDICATION GUIDELINES Your partner in outpatient radiology We are dedicated to achieving the highest levels of quality and safety in outpatient imaging. We developed these Imaging Indication Guidelines to help you choose imaging examinations that will answer your clinical questions for your patients. We hope they will assist you in the pre-authorization and Medicare Appropriate Use Criteria processes. Quality Convenience Affordability High quality reports Appointments when and Reduce your out-of-pocket and equipment where you need them imaging cost 2 | IMAGING INDICATION GUIDELINES Notes IMAGING INDICATION GUIDELINES | 3 Notes 4 | IMAGING INDICATION GUIDELINES We are dedicated to achieving the highest levels of quality and safety, and have developed these Imaging Indication Guidelines to provide information and guidance during the radiology ordering process. General Contrast Guidelines Choose “Radiologist Discretion” on the order and our board certified radiologists will select the contrast option suited to your patient’s history and condition. This will facilitate thepre -authorization process. Generally, contrast is indicated whenever you are concerned about: • Infection (except uncomplicated sinusitis) • Organ integrity • Tumor or cancer • Possible disc after lumbar surgery • Vascular abnormality (except stroke) Generally, contrasted MRI scans are performed with and without contrast. Generally, CT scans are performed either with or without contrast in order to limit the patient’s radiation dose. Without & with contrast CT scans are indicated for these conditions: • Thoracic aortic dissection • Kidney mass • Liver mass • Painless hematuria • Pancreas mass • Bladder mass • Adrenal gland mass Exams Commonly Confused: • Cervical CT or MRI (for vs. Soft tissue neck CT or MRI (for soft cervical spine) tissue, e.g.
    [Show full text]
  • Magnetic Resonance Cholangio-Pancreatography in Patients with Acute Cholecystitis and Cholestatic Liver Pattern - What to Expect?
    Jemds.com Original Research Article Magnetic Resonance Cholangio-Pancreatography in Patients with Acute Cholecystitis and Cholestatic Liver Pattern - What to Expect? Ali Al Orf1, Khawaja Bilal Waheed2, Ali Salman Alshehri3, Mushref Ali Algarni4, Bilal Altaf5, Muhammad Amjad6, Ayman Abdullah Alhumaid7, Zechariah Jebakumar Arulanantham8 1Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 2Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 3Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 4Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 5Department of General Surgery, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 6Department of Internal Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 7Department of Radiology, King Fahad Military Medical Complex, Dhahran, Saudi Arabia. 8Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia. ABSTRACT BACKGROUND Acute cholecystitis is a potentially serious condition and usually needs to be treated Corresponding Author: in the hospital. Identification of a common bile duct (CBD) stone before Khawaja Bilal Waheed, Consultant General Radiologist, cholecystectomy is of concern for the treating physicians as management may King Fahad Military Medical Complex, change. Magnetic Resonance Cholangiopancreatography (MRCP) can help in Dhahran, Saudi Arabia. identifying causes of biliary obstruction (if present) and adequately delineate biliary E-mail: [email protected] tree in selected patients with limited or abnormal ultrasounds and cholestatic liver DOI: 10.14260/jemds/2020/530 pattern. Therefore, we aim to demonstrate imaging findings of MRCP in such patients of acute cholecystitis, and highlight the diagnostic ability of MRCP in biliary ductal How to Cite This Article: evaluation as well.
    [Show full text]
  • Table 1. Summary of Criterion Evidence
    SUMMARY TABLE Table 1: Summary of Criterion Evidence Domain 1: Criteria Related to the Underlying Health Condition Criterion Synthesized Information 1 Size of the affected No estimates of point prevalence of acute cholecystitis were found in the literature. An Ontario population hospital-based study29 estimated the annual incidence of acute cholecystitis from 1992 to 2000 to be 0.88 people per 1,000 population. The size of affected population is more than 1 in 10,000 (0.01%) and less than or equal 1 in 1,000 (0.1%) 2 Timeliness and Saskatchewan hospital guidelines indicate that cholescintigraphy for diagnosis of suspected acute urgency of test cholecystitis should be conducted within 24 hours (Patrick Au, Acute and Emergency Services results in planning Branch, Saskatchewan Ministry of Health: unpublished data, 2011) patient management The target time frame for performing the test is in 24 hours or less and obtaining the 99mTc-based test results in the appropriate timely manner for the underlying condition has significant impact on the management of the condition or the effective use of health care resources. 3 Impact of not If a test for diagnosing acute cholecystitis is not available, treatment might be delayed and performing a complications associated with high mortality rates might be more likely to develop. Complications diagnostic imaging from acute cholecystitis occur in around 20% of patients and complicated acute cholecystitis is test on mortality associated with a mortality rate of around 25%.33 Perforation of the gallbladder, which occurs in related to the 3% to 15% of patients with cholecystitis, has a 60% mortality rate.34 Acute acalculous cholecystitis underlying condition has a mortality rate of around 30%.35 Diagnostic imaging test results can have minimal impact on mortality.
    [Show full text]
  • Cholescintigraphy Stellingen
    M CHOLESCINTIGRAPHY STELLINGEN - • - . • • ' - • i Cholescintigrafie is een non-invasief en betrouwbaar onderzoek in de diagnostiek bij icterische patienten_doch dient desalniettemin als een complementaire en niet als compfititieye studie beschouwd te worden. ]i i Bij de abceptatie voor levensverzekeringen van patienten met ! hypertensie wordt onvoldoende rekening gehouden met de reactie jj op de ingestelde behandeling. ! Ill | Ieder statisch scintigram is een functioneel beeld. | 1 IV ] The purpose of a liver biopsy is not to obtain the maximum \ possible quantity of liver tissue, but to obtain a sufficient 3 quantity with the minimum risk to the patient. j V ( Menghini, 1970 ) I1 Bij post-traumatische verbreding van het mediastinum superius is I angiografisdi onderzoek geindiceerd. VI De diagnostische waarde van een radiologisch of nucleair genees- kundig onderzoek wordt niet alleen bepaald door de kwaliteit van de apparatuur doch voonnamelijk door de deskundigheid van de onderzoeker. VII Ultra sound is whistling in the dark. VIII De opname van arts-assistenten, in opleiding tot specialist, in de C.A.O. van het ziekenhuiswezen is een ramp voor de opleiding. IX De gebruikelijke techniek bij een zogenaamde "highly selective vagotomy" offert meer vagustakken op dan noodzakelijk voor reductie van de zuursecretie. X Het effect van "enhancing" sera op transplantaat overleving is groter wanneer deze sera tijn opgewekt onder azathioprine. XI Gezien de contaminatiegraad van in Nederland verkrijgbare groenten is het gebraik als rauwkost ten stelligste af te raden. j Het het ontstaan van een tweede maligniteit als complicatie van 4 cytostatische therapie bij patienten met non-Hodgkin lymphoma, | maligne granuloom en epitheliale maligne aandoeningen dient, j vooral bij langere overlevingsduur, rekening gehouden te worden.
    [Show full text]
  • Gallstone Disease Diagnosis and Management of Cholelithiasis, Cholecystitis and Choledocholithiasis
    Internal Clinical Guidelines Team Document information (i.e. version number etc) Gallstone disease Diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis Clinical Guideline <…> Methods, evidence and recommendations 2014 Draft for Consultation National Institute for Health and Care Excellence Disclaimer Healthcare professionals are expected to take NICE clinical guidelines fully into account when exercising their clinical judgement. However, the guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer. Copyright National Institute for Health and Care Excellence, Date xxxx. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes within the NHS. No reproduction by or for commercial organisations is allowed without the express written permission of the National Institute for Health and Care Excellence. Gallstone disease Contents Contents 1 Overview .................................................................................................................................. 7 Patient-centred care ................................................................................................................ 7 2 Summary Section .................................................................................................................. 9 Guideline development group (GDG) members...................................................................
    [Show full text]
  • Cholecystocolonic Fistula: Facts and Myths. a Review of the 231
    J Hepatobiliary Pancreat Surg (2009) 16:8–18 DOI 10.1007/s00534-008-0014-1 REVIEW ARTICLE Cholecystocolonic fistula: facts and myths. A review of the 231 published cases Renato Costi Æ Bruto Randone Æ Vincenzo Violi Æ Olivier Scatton Æ Leopoldo Sarli Æ Olivier Soubrane Æ Bertrand Dousset Æ Thierry Montariol Received: 19 March 2008 / Accepted: 28 April 2008 / Published online: 17 December 2008 Ó Springer 2008 Abstract Resolution of colonic biliary ileus by interventional Background Cholecystocolonic fistula (CCF) is the sec- endoscopy is reported. ond most common cholecystoenteric fistula and is often Conclusion CCF should be considered in differential discovered intraoperatively, resulting in a challenging sit- diagnosis of diarrhea, especially in old, female patients. A uation for the surgeon, who is forced to switch to a possible second hepatobiliary abnormality should be complex procedure, often in old, unfit patients. Manage- always investigated. Extemporaneous frozen section ment of this uncommon but possible finding is still ill should be performed if gallbladder cancer is suspected. defined. Depending on clinical presentation, different treatments for Methods An extensive review of 160 articles published CCF are indicated, ranging from minimally invasive pro- from 1950 to 2006 concerning 231 cases of CCF was cedures to extensive resection. performed. Results CCF is mostly an affliction of women in their Keywords Cholecystocolonic fistula Á Biliary ileus Á sixth to seventh decades and is rarely diagnosed preoper- Diagnosis Á Treatment Á Laparoscopy atively. Chronic diarrhea is the key symptom in nonemergency patients, but, in one-fourth of cases, CCF presents with an acute onset, mostly biliary ileus.
    [Show full text]
  • Nuclear Medicine Tests for Acute Gastrointestinal Conditions Thomas W
    Nuclear Medicine Tests for Acute Gastrointestinal Conditions Thomas W. Allen, MD,* and Mark Tulchinsky, MD Acute cholecystitis (AC) and lower-gastrointestinal (GI) bleeding are 2 emergencies commonly encountered in nuclear medicine. Evidence of AC on hepatobiliary scintigraphy (HBS) allows for confident diagnosis and provides support for definitive surgical treatment. Proper patient preparation is essential for HBS including fasting and the use of pharmacologic adjuncts is sometimes required. Pharmacologic adjuncts may also be administered during HBS to shorten the length of the examination and increase its specificity. In the interpretation of HBS, there are several sources of false-positive results to be aware of, most commonly chronic cholecystitis. False-negative results on HBS are usually the result of mistaking another structure, such as a dilated cystic duct, for the gallbladder. Abdominal ultrasound is the appropriate initial test in patients with suspected AC, but HBS is an excellent second tier test for the diagnosis of AC in the work-up of indeterminate cases by sonography. GI bleeding scintigraphy plays an important role in the evaluation and management of patients with acute lower-GI bleeding. Scintigraphy serves to localize sites of active GI bleeding and stratify those patients who would benefit from aggressive treatment (surgery or arteriography) vs those who can be managed medically. Pretest involvement of respective services is critical for successful bleeding site confirmation and therapy by interventional radiology or surgery or both. Single photon emission computed tomography/computed tomography erythrocyte scintigraphy has demonstrated superior accuracy and precision over planar scintigraphy in the diagnosis of acute GI bleeding. Additionally, single photon emission computed tomo- graphy/computed tomography scintigraphy of GI bleeding provides useful supplemental anatomical information that benefits patient management.
    [Show full text]
  • Bronchobiliary Fistula Detected by Cholescintigraphy
    Bronchobiliary Fistula Detected by Cholescintigraphy Michael G. Velchik, Gerald M. Roth, William Wegener, and Abass Alavi Hospital of The UniversityofPennsylvania, Philadelphia, Pennsylvania the symptoms recurred. She re-presented to her physician who We present a case of a bronchobiliary fistula initially de witnessed the patient coughing up bilious material. Decreased tected by hepatobiliaryscintigraphy. The patient developed breath sounds and dullness to percussion were noted at the bilioptysis 18 mo after undergoing a right hepatic lobec right lung base. Her abdomen was slightly distended and tomy and resection of the common bile duct for tholangio shifting dullness could be elicited. carcinoma.The procedurewas complicatedby the devel Laboratoryvalueson admissionshowedan elevatedtotal opment of a subphrenic abscess that required percuta bilirubin of 2.0 mg/dl (normal: 0.0—1.2),with a conjugated neous biliary drainage. fraction of0.7 mg/dl (0.0-0. 1).The GGTP measured 449 UI 1(0—40)and the alkaline phosphatase measured 630 U/I (35— J NucI Med 1991; 32:136—138 125).The transaminase, LDH, and CPK levels were all within the normal range. She had an elevated white blood cell count of 27.4 K/@J,with 92% polymorphonuclear cells, 7% band cells, and 1% lymphocytes on a manual leukocyte differential ronchobiliary fistula is a rare disorder, which is count. Multipleelectrolyteabnormalitieswerealsonotedwith characterized by bilioptysis that may be congenital in a sodium level of 123 mmol/l (133—143), a chloride level of origin, but which is more commonly associated with 89 mmol/l (97—107),a CO2 content of 21 mmol/l (24—32),a glucoselevelof 120mg/dl (70—110),a blood urea nitrogenof trauma, surgery, or with hepatic abscess and/or para 24 mg/dl (10—20),and a creatinine level of 0.5 mg/dl (0.6— sitic liver disease.
    [Show full text]
  • Appropriate Use Criteria for Hepatobiliary Scintigraphy in Abdominal Pain
    Appropriate Use Criteria for Hepatobiliary Scintigraphy in Abdominal Pain Gary Dillehay1, Zvi Bar-Sever2, Manuel Brown1, Richard Brown1, Edward Green1, Marie Lee1, Joseph K. Lim3, Darlene Metter1, Andrew Trout1, Robert Wagner1, Sachin Wani3, Harvey Ziessman1, Julie Kauffman1, Sukhjeet Ahuja1, and Kevin Donohoe1 1Society of Nuclear Medicine and Molecular Imaging; 2European Association of Nuclear Medicine; and 3American Gastroenterological Association EXECUTIVE SUMMARY appropriate. In addition, these recommendations do not preclude other testing. This document describes common clinical presenta- 99mTc-labeled hepatobiliary iminodiacetic acid (HIDA) scintig- tions in patients with abdominal pain in which HIDA scintigraphy raphy is an important adjunct to the evaluation of patients with may be helpful. Referring providers should consider patient history, abdominal pain. The introduction of radiopharmaceuticals that physical examination results, and previously acquired test results allowed the performance of these studies in patients with elevated before considering HIDA scintigraphy. This document is presented bilirubin levels expanded the clinical use of this important diag- to assist the health care practitioner in the appropriate use of HIDA nostic imaging technology. The proper use of HIDA scintigraphy scintigraphy in evaluating patients with abdominal pain but is not requires an understanding of the physiology of the hepatobiliary intended to replace clinical judgment. system in both health and disease states, the metabolism of hep- HIDA
    [Show full text]